LCG Talks Coffee Mornings EP3 | Discussing the Novel Food FSA announcement with B3 Labs

LCG Talks Coffee Mornings EP3 | Discussing the Novel Food FSA announcement with B3 Labs

This week we are joined by Marc and Haseeb from B3 Labs, a UK based white label CBD manufacturer, to discuss the deadline (31 March 2021) given to the CBD industry to submit a valid novel food authorisation application by The Food Standards Agency (FSA) to allow them to remain on the market.

We ask the B3 Labs team their thoughts on how the announcement will affect manufacturers who are already on the market, including big high street retailers and those looking to enter the market and they highlight the importance of investment from companies to reach compliance. 

Marc and Haseeb also share how the announcement of the upcoming guidelines has changed production, they explain the process to get to market in terms of production and compliance, how you can ensure consistency in your products and explain what white labelling is and the pros and cons of going down this route. They also discuss whether the FSA announcement has put innovation to a halt completely, or whether this just a temporary measure that will see a boom in the future.

 

You can watch this episode here.

 

We hope you can join us next week Wednesday at 10am where we look forward to answering your questions.

Registration Link:
After registering, you will receive a confirmation email containing information about joining the webinar.
Please note that you will have a better chance of getting your questions answered live, by submitting them in advance.
If you would like further help or would like to speak in more detail to a member of the London Canna Group team, please email us at info@londoncbdgroup.com and we will get back to you.